Responding to the Supreme Court’s Arthrex decision, the U.S. Patent and Trademark Office issued interim rules today governing the PTO director’s review of Patent Trial and Appeal Board decisions.

The rules state that the director can review final written decisions of the PTAB on his or her own motion or at the request of the parties. The director’s review will be de novo.